A Phase I Study of TS-172 in Healthy Adult Subjects (Single and Multiple Doses)

NCT04979572 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

41

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Adult Subjects

Interventions

DRUG: TS-172
DRUG: Placebo

Sponsor

Taisho Pharmaceutical Co., Ltd.